
Results
25
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
25 companies
Genomed Spólka Akcyjna
Market Cap: zł40.7m
Provides DNA and RNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł31.00
7D
8.4%
1Y
20.2%
Celon Pharma
Market Cap: zł1.1b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.
CLN
zł20.40
7D
-1.7%
1Y
-10.3%
Biogened
Market Cap: zł46.4m
Produces and sells cosmetics and toiletries in Poland.
BGD
zł19.60
7D
2.6%
1Y
-26.9%
Selvita
Market Cap: zł520.4m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł27.95
7D
-1.9%
1Y
-15.6%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł451.1m
A biopharmaceutical company, develops therapeutic molecules for treating oncological and autoimmune diseases in Poland.
CTX
zł70.70
7D
-3.8%
1Y
75.4%
Bioceltix
Market Cap: zł437.6m
Engages in the development of veterinary biologics based on mesenchymal stem cells.
BCX
zł80.40
7D
-3.6%
1Y
-23.3%
NanoGroup
Market Cap: zł106.1m
Operates as a biotechnology company in Poland.
NNG
zł2.49
7D
1.6%
1Y
-5.9%
genXone
Market Cap: zł18.2m
Operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.
GX1
zł5.50
7D
-4.5%
1Y
0%
Poltreg
Market Cap: zł155.0m
A biotechnology company, researches and develops therapies for autoimmune diseases in Poland.
PTG
zł25.90
7D
-3.7%
1Y
-13.7%
Green Zebras Spolka Akcyjna
Market Cap: zł15.9m
Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.
GRZ
zł9.90
7D
-4.8%
1Y
18.6%
Ryvu Therapeutics
Market Cap: zł381.9m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł18.22
7D
4.5%
1Y
-39.3%
Molecure
Market Cap: zł126.7m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł6.17
7D
0.3%
1Y
-22.1%
Labocanna
Market Cap: zł4.6m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.22
7D
2.9%
1Y
-29.4%
HyEnergy
Market Cap: zł77.9m
Provides genetic diagnostic solutions in Poland.
HEN
zł2.32
7D
0%
1Y
-34.6%
BIOTON
Market Cap: zł326.7m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł3.80
7D
-2.7%
1Y
-8.7%
Stem Cells Spin
Market Cap: zł19.8m
Operates as a biotechnology company in Poland.
SCS
zł0.49
7D
10.5%
1Y
35.0%
Urteste
Market Cap: zł68.4m
Engages in the research and development of diagnostic tests for cancers in Poland.
URT
zł45.30
7D
3.9%
1Y
-13.2%
Genomtec
Market Cap: zł57.2m
Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.
GMT
zł3.78
7D
-4.3%
1Y
-39.0%
Read-Gene
Market Cap: zł58.8m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł4.99
7D
0.2%
1Y
-7.2%
Cannabis Poland
Market Cap: zł12.8m
Operates in the medical cannabis industry in Poland.
CBD
zł0.17
7D
-1.7%
1Y
-44.9%
Tecnovatica
Market Cap: zł6.2m
Does not have significant operations.
TEC
zł0.60
7D
20.0%
1Y
60.4%
Medicofarma Biotech
Market Cap: zł26.8m
Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.
MDB
zł0.39
7D
0.5%
1Y
26.6%
MultiQure
Market Cap: zł38.7m
A biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.
MQR
zł3.06
7D
-4.1%
1Y
-54.7%
Mabion
Market Cap: zł121.9m
A biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland.
MAB
zł7.52
7D
0%
1Y
-21.4%
Synthaverse
Market Cap: zł220.9m
A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents for use in oncology, gynecology, hematology, immunology, and related therapeutic areas in Poland, the rest of the European Union, and internationally.
SVE
zł2.92
7D
-0.8%
1Y
-40.5%